BRO:NYE-Brown & Brown Inc (USD)

COMMON STOCK | Insurance Brokers | NYE

Last Closing Price

USD 62.65

Change

-1.25 (-1.96)%

Market Cap

USD 17.99B

Volume

1.81M

Avg Analyst Target

USD 60.82 (-2.92%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Brown & Brown, Inc. markets and sells insurance products and services in the United States, Bermuda, Canada, Cayman Islands, Ireland, and the United Kingdom. It operates through four segments: Retail, National Programs, Wholesale Brokerage, and Services. The company offers builders risk, group medical and pharmaceutical, property, commercial auto, homeowners, reinsurance, crop and hail, inland marine, retirement benefit, cyber, disability, risk mitigating warranty products, directors and officers, management liability, errors and omissions, medical stop loss, term life, excess liability, personal auto, umbrella, general liability, prescription drug, workers compensation, and group dental insurance products. It also provides professional liability and related package insurance products for dentistry, legal, eyecare, insurance, financial, physicians, and real estate title professionals, as well as supplementary insurance-related products for weddings, events, medical facilities, and cyber liability; homeowners and personal property policies, residential earthquake, and private passenger automobile and motorcycle coverage; commercial and public entity-related programs; and flood insurance, commercial difference-in-conditions, all-risk commercial property, coastal property programs, lender-placed solutions, sovereign Indian nations, and parcel insurance. In addition, it provides markets and sells excess and surplus commercial insurance products, such as personal lines, homeowners, yachts, jewelry, commercial property and casualty, commercial automobile, garage, restaurant, builder's risk, and inland marine lines; and third-party claims administration and medical utilization management services in the workers' compensation and all-lines liability arenas, as well as Medicare Set-aside, Social Security disability, Medicare benefits advocacy, and claims adjusting services. The company was founded in 1939 and is headquartered in Daytona Beach, Florida.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-10-27 )

Largest Industry Peers for Insurance Brokers

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
MMC Marsh & McLennan Companies Inc

-1.27 (-0.75%)

USD85.28B 31.93 19.39
AON Aon plc

-3.37 (-1.05%)

USD72.29B 35.24 23.33
AJG Arthur J. Gallagher & Co

-1.99 (-1.21%)

USD33.95B 36.69 21.58
CRD-B Crawford & Company

-0.21 (-2.44%)

USD0.47B 8.99 5.64
CRD-A Crawford & Company

-0.33 (-3.65%)

USD0.47B 9.45 5.64

ETFs Containing BRO

Symbol Name Weight Mer Price(Change) Market Cap
IVOG Vanguard S&P Mid-Cap 400 .. 0.00 % 0.15 %

-2.28 (-1.09%)

USD1.09B
KIE SPDR S&P Insurance ETF 0.00 % 0.35 %

-0.90 (-2.18%)

USD0.71B
PXMG Invesco S&P MidCap Moment.. 0.00 % 0.39 %

N/A

USD0.61B
JMIN JPMorgan U.S. Minimum Vol.. 0.00 % 0.12 %

-0.41 (-1.12%)

USD0.02B
FSMD Fidelity Covington Trust .. 0.00 % 0.29 %

-0.57 (-1.63%)

USD0.06B
KLCD KFA Large Cap Quality Div.. 0.00 % 0.42 %

-0.41 (-1.20%)

USD0.07B
AGED:LSE iShares Ageing Population.. 0.00 % 0.40 %

-0.05 (-0.60%)

USD0.98B
AGES:LSE iShares IV Public Limited.. 0.00 % 0.40 %

-3.13 (-0.56%)

USD0.98B
FCTR:LSE WisdomTree Issuer ICAV - .. 0.00 % 0.30 %

N/A

USD2.02M
USMF:LSE WisdomTree Issuer ICAV - .. 0.00 % 0.30 %

N/A

USD2.02M
HSMV First Trust Horizon Manag.. 0.00 % 0.80 %

-0.51 (-1.51%)

N/A
SIXL 6 Meridian Low Beta Equit.. 0.00 % 0.88 %

-0.40 (-1.16%)

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Insurance Brokers)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 32.15% 67% D+ 80% B-
Dividend Return 0.59% 17% F 12% F
Total Return 32.73% 67% D+ 79% C+
Trailing 12 Months  
Capital Gain 41.84% 50% F 64% D
Dividend Return 0.84% 17% F 11% F
Total Return 42.68% 50% F 62% D-
Trailing 5 Years  
Capital Gain 240.86% 100% A+ 93% A
Dividend Return 8.34% 50% F 25% F
Total Return 249.20% 83% B 93% A
Average Annual (5 Year Horizon)  
Capital Gain 23.85% 83% B 84% B
Dividend Return 1.09% 17% F 26% F
Total Return 24.95% 83% B 84% B
Risk Return Profile  
Volatility (Standard Deviation) 11.95% 100% A+ 79% C+
Risk Adjusted Return 208.69% 100% A+ 100% A+
Market Capitalization 17.99B 50% F 87% B+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Insurance Brokers)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 31.34 67% D+ 24% F
Price/Book Ratio 4.75 50% F 22% F
Price / Cash Flow Ratio 24.94 50% F 18% F
EV/EBITDA 21.78 33% F 25% F
Management Effectiveness  
Return on Equity 14.92% 33% F 64% D
Return on Invested Capital 9.85% 17% F 76% C
Return on Assets 5.57% 67% D+ 77% C+
Debt to Equity Ratio 53.96% 100% A+ 60% D-
Technical Ratios  
Short Ratio 1.21 83% B 66% D
Short Percent 1.74% 33% F 68% D+
Beta 0.71 50% F 74% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.